The biology of the immune system

JAMA

Volumn 278, Issue 22, 1997, Pages 1804-1814

  Huston, David P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENT; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ACTIVE IMMUNIZATION; ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL MEDICINE; GENE REARRANGEMENT; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN GENE; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0031440398     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.22.1804     Document Type: Review

References (90)

1. Lewis D, Harriman GR. Cells and tissues of the immune system. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, eds. Clinical Immunology Principles and Practice. St Louis, Mo: Mosby-Year Book Inc; 1996;1:15-38.
2. Nelson D. Cellular interactions in the human immune response. In: Stiehm ER, ed. Immunological Disorders in Infants and Children. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1989:15-28.
3. Steinman L. Autoimmune disease. Sci Am. 1993; 269:106-114.
4. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994;76:287-299.
5. Jerne NK. Idiotypic networks and other preconceived ideas. Immunol Rev. 1984;79:5-24.
6. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science. 1996;272:50-53.
7. Weissmann IL, Cooper MD. How the immune system develops. Sci Am. 1993;269:64-71.
8. Brodsky FM, Guagliardi L. The cell biology of antigen processing and presentation. Ann Rev Immunol. 1991;9:707-744.
9. Davis MM. T cell receptor gene diversity and selection. Ann Rev Biochem. 1990;59:475-496.
10. Schatz DG, Oettinger MA, Schlissel MS. V(D)J recombination. Ann Rev Immunol. 1992;10:359-383.
11. Dexter TM, Spooncer M. Growth and differentiation in the hematopoietic system. Ann Rev Cell Biol. 1987;3:423-441.
12. Ager A, Callard R, Ezine S, et al. Immune receptor supplement. Immunol Today. 1997;1:1-36.
13. Rodgers JR, Rich RR. Antigens and antigen presentation. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, eds. Clinical Immunology Principles and Practice. St Louis, Mo: Mosby-Year Book Inc; 1996:114-131.
14. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Ann Rev Immunol. 1993;11:403.
15. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
16. Bjorkman PJ. MHC restriction in three dimensions. Cell. 1997;89:167-170.
17. Bjorkman PJ, Saper MA, Samraoui B, et al. Structure of the human class I histocompatibility antigen, HLA-A-2. Nature. 1987;329:506-512.
18. Brown JH, Jardetzky TS, Gorga JC, et al. The three-dimensional structure of the human class II histocompatibility antigen, HLA-DR1. Nature. 1993;364:33-39.
19. Trowsdale J, Tagoussis J, Campbell RD. Map of the human MHC. Immunol Today. 1991;12:443-446.
20. Bjorkman P, Parham P. Structure, function and diversity of class I major histocompatibility complex molecules. Ann Rev Biochem. 1990;59:253-288.
21. Parham P, Lawlor DA, Salter RD, et al. HLA-A, -B, -C: patterns of polymorphism in peptide binding proteins. In: DuPont B, ed. Immunobiology of HLA. New York, NY: Springer-Verlag; 1987;2:10-32.
22. Salter RD, Benjamin RJ, Wesley PK, et al. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature. 1990;345:41-46.
23. Goodman JW. Antigen presentation and the major histocompatability complex. In: Stites DP, Terr AI, Parslow TG, eds. Basic & Clinical Immunology. 8th ed. Norwalk, Conn: Appleton & Lange; 1994:58-65.
24. Konig R, Huang L-Y, Germain RN. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature. 1992;356:796-798.
25. Cammarota G, Scheirle A, Takacs B, et al. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature. 1992;356:799-801.
26. Skoskiewicz MJ, Colvin RB, Schneeberger EE, et al. Widespread and selective induction of major histocompatibility complex-determined antigens by γ interferon. J Exp Med. 1985;162:1645-1664.
27. Todd JA, Bell JI, McDevitt HO. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987;329: 599-604.
28. Dorman JS, LaPorte RE, Stone RA, et al. World-wide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQβ chain. Proc Natl Acad Sci U S A. 1990;87:7370-7374.
29. Tiwari JL, Terasaki PI, eds. HLA and Disease Associations. New York, NY: Springer-Verlag; 1985.
30. Brewerton D, Caffrey M, Hart F. Ankylosing spondylitis and HLA-A27. Lancet. 1973;1:904-907.
31. MacLean L. HLA-B27 subtypes. Ann Rheum Dis. 1991;51:929-931.
32. Nepom GT, Byers P, Seyfried C, et al. HLA genes associated with rheumatoid arthritis. Arthritis Rheum. 1989;32:15-21.
33. Gregorsen PK, Silver J, Winchester RJ. The shared epitope hypothesis. Arthritis Rheum. 1987; 30:1205-1213.
34. Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994;368:215-221.
35. Beckman EM, Porcelli SA, Morita CT, et al. Recognition of a lipid antigen by CD1-restricted α/β+ T cells. Nature. 1994;372:691-694.
36. Sieling PA, Chatterijee D, Porcelli SA, et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 1995;269:227-230.
37. Bjorkman PJ, Davis MM. Model for the interaction of T-cell receptors with peptide/MHC complexes. Cold Spring Harbor Symp Quant Biol. 1989; 54:365-373.
38. Haynes BF, Denning SM, Singer KH, et al. Ontogeny of T-cell precursors. Immunol Today. 1989; 10:87-91.
39. Boyd RL, Hugo P. Towards an integrated view of thymopoiesis. Immunol Today. 1991;12:71-79.
40. Nikolic-Zugic J. Phenotypic and functional stages in the intrathymic development of αβ T cells. Immunol Today. 1991;12:65-70.
41. Haynes B, Denning SM, Le PT, et al. Human intrathymic T cell differentiation. Semin Immunol. 1990;2:67-77.
42. Kruisbeek AM. Development of αβ T cells. Curr Opin Immunol. 1993;5:227-234.
43. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Ann Rev Immunol. 1993;11:637-685.
44. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334: 395-402.
45. Ashwell JD, Klausner RD. Genetic and mutational analysis of the T-cell antigen receptor. Ann Rev Immunol. 1990;8:139-167.
46. Frank SJ, Engel I, Rutledge TM, et al. Structure/function analysis of the invariant subunits of the T cell antigen receptor. Semin Immunol. 1991; 3:299-311.
47. Siegel JN, June CH. Signal transduction and T lymphocyte activation. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, eds. Clinical Immunology Principles and Practice. St Louis, Mo: Mosby-Year Book Inc; 1996;1:192-216.
48. June CH, Bluestone JA, Nadler LM, et al. The B7 and CD28 receptor families. Immunol Today. 1994;15:321-331.
49. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell response to antigen. Ann Rev Immunol. 1993;11:191-212.
50. Miceli MC, Parnes JR. Role of CD4 and CD8 in T cell activation and differentiation. Adv Immunol. 1993;53:59-122.
51. Julius M, Maroun CR, Haughn L. Distinct roles for CD4 and CD8 as co-receptors in antigen receptor signaling. Immunol Today. 1993;14:177-183.
52. Mosmann T. Cytokines and immune regulation. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, eds. Clinical Immunology Principles and Practice. St Louis, Mo: Mosby-Year Book Inc; 1996:217-230.
53. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383: 787-793.
54. Drake CG, Kotzin BL. Superantigens. J Clin Immunol. 1992;12:149-162.
55. Huston DP, Kavanaugh AF, Rohane PW, Huston MM. Immunoglobulin deficiency syndromes and therapy. J Allergy Clin Immunol. 1991;87:1-19.
56. Rolink A, Melchers F. Molecular and cellular origins of B lymphocyte diversity. Cell. 1991;66: 1081-1094.
57. Banchereau J, Rousset F. Human B lymphocytes. Adv Immunol. 1992;52:125-262.
58. Alt FW, Oltz EM, Young F, et al. VDJ recombination. Immunol Today. 1992;13:306-314.
59. Goodwin RG, Lupton S, Schmierer A, et al. Human interleukin 7. Proc Natl Acad Sci U S A. 1989; 86:302-306.
60. Silverton EW, Navia MA, Davies DR. Three-dimensional structure of an intact human immunoglobulin. Proc Natl Acad Sci U S A. 1977;74:5140-5144.
61. Davies DR, Padlan EA, Segal DM. Three-dimensional structure of immunoglobulins. Ann Rev Biochem. 1975;44:639-667.
62. Alt FW, Bothwell ALM, Knapp M, et al. Synthesis of secreted and membrane-bound immunoglobulin M heavy chains is directed by mRNAs that differ at their 3′ ends. Cell. 1980;20:293-301.
63. Early P, Rogers J, Davis M, et al. Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways. Cell. 1980;20:313-319.
64. Reth M. Antigen receptors on B lymphocyte. Ann Rev Immunol. 1992;10:97-121.
65. Clark MR, Campbell KS, Kazlauskas A, et al. The B cell antigen receptor complex. Science. 1992;258:123-126.
66. Moller G, ed. The B-cell antigen receptor complex. Immunol Rev. 1993;132:1-206.
67. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B cell activation. Immunol Today. 1992;13:431-433.
68. Armitage RJ, Macduff BM, Spriggs MK, et al. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol. 1993;150:3671-3680.
69. Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Ann Rev Immunol. 1994;12:881-922.
70. Aruffo A, Farrington M, Hollenbaugh D, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291-300.
71. Pene J, Rousset F, Briere F, et al. IgE production by normal human lymphocytes is induced by interleukin-4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A. 1988;85:6880-6884.
72. Jabara HJ, Fu SM, Geha RS, et al. CD40 and IgE. J Exp Med. 1990;172:1861-1864.
73. Defrance T, Vanbervliet B, Briere F, et al. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992;175:671-682.
74. Lebman DA, Nomura DY, Coffman RL, et al. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching. Proc Natl Acad Sci U S A. 1990;87:3962-3966.
75. DeFranco AL. Molecular aspects of B-lymphocyte activation. Ann Rev Cell Biol. 1987;3:143-178.
76. Mond JJ, Lees A, Snapper CM. T cell independent antigens type 2. Ann Rev Immunol. 1995;13:655-692.
77. DeFranco AL. B lymphocyte activation. In: Paul WE, ed. Fundamental Immunology. 3rd ed. New York, NY: Raven Press; 1993:505-529.
78. O'Shea JJ. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity. 1997;7:1-11.
79. Ihle JN. STATs. Cell. 1996;84:331-334.
80. Leonard WJ. Dysfunctional cytokine receptor signaling in severe combined immunodeficiency. J Invest Med. 1996;44:304-311.
81. Frank MM, Fries LF. The role of complement in inflammation and phagocytosis. Immunol Today. 1991;12:322-326.
82. Figuera JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4:359-395.
83. Berliner S. Familial systemic lupus erythematosus and C4 deficiency. Scand J Rheumatol. 1981;10: 280-282.
84. Glass D. Inherited deficiency of the second component-complement rheumatic disease association. J Clin Invest. 1976;58:853.
85. Huston DP, Bressler RB. Urticaria and angioedema. In: RK Bush, ed. Medical Clinics of North America. Philadelphia, Pa: WB Saunders Co; 1992; 76:805-840.
86. Konoshita T, Medof ME, Silber R, et al. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med. 1985;162:75-92.
87. Smith CW. Cellular adhesion and interactions. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W, eds. Clinical Immunology Principles and Practice. St Louis, Mo: Mosby-Year Book Inc; 1996:176-191.
88. Kishimoto TK, Anderson DC. The role of integrins in inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York, NY: Raven Press; 1992:353-406.
89. Nagata S. Apoptosis by death factor. Cell. 1997; 88:355-365.
90. Ferguson TA, Griffith TS. Cell death and the immune response: a lesson from the privileged. J Clin Immunol. 1997;17:1-10.